SCHEMBL3984162

SCHEMBL3984162

C#CCNCCc1cccc(OC)c1

nearest known ligand 0.64

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 3/20 0.64
CHRM1 P11229 2/20 0.64
CHRM3 P20309 2/20 0.64
ACHE P22303 3/20 0.64
BCHE P06276 3/20 0.57
TAAR1 Q96RJ0 1/20 0.54
KDM4E B2RXH2 3/20 0.52
ALDH1A1 P00352 2/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
TDP1 Q9NUW8 1/20 0.52
MTNR1A P48039 1/20 0.50
MTNR1B P49286 1/20 0.50
NPC1 O15118 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18114970 0.87 CHRM2 (0.77) CHRM2CHRM1CHRM3BCHETAAR1
SCHEMBL29351421 0.84 CHRM2 (0.62) CHRM2CHRM1CHRM3BCHEKDM4E
SCHEMBL28696933 0.84 CHRM2 (0.62) CHRM2CHRM1CHRM3BCHEKDM4E
SCHEMBL2759534 0.82 CHRM2 (0.70) CHRM2CHRM1CHRM3BCHETAAR1
SCHEMBL9517424 0.82 CHRM2 (0.70) CHRM2CHRM1CHRM3BCHETAAR1
SCHEMBL10645373 0.81 CHRM2 (0.68) CHRM2CHRM1CHRM3BCHETAAR1
SCHEMBL15681916 0.81 CHRM2 (0.68) CHRM2CHRM1CHRM3BCHETAAR1
Bromide SCHEMBL9649046 0.81 CHRM2 (0.68) CHRM2CHRM1CHRM3BCHETAAR1
SCHEMBL6896901 0.80 CHRM2 (0.72) CHRM2CHRM1CHRM3BCHETAAR1
SCHEMBL5703462 0.80 TAAR1 (0.61) CHRM2CHRM1CHRM3TAAR1MTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2061449-A1 SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES Leo Pharma A/S (DK) 2009-05-27 EP disclosed
WO-2008019690-A1 SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES LEO PHARMA A/S (DK) 2008-02-21 WO disclosed